Digital Diabetes Management Market Intelligence Report - Global Forecast to 2027

Digital Diabetes Management Market Intelligence Report - Global Forecast to 2027

The Global Digital Diabetes Management Market is projected to reach USD 27,041.42 million by 2027 from USD 9,317.43 million in 2021, at a CAGR 19.43% during the forecast period.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

• The Americas Digital Diabetes Management Market size was estimated at USD 3,131.84 million in 2021 and expected to reach USD 3,749.04 million in 2022, at a CAGR 19.57% to reach USD 9,154.66 million by 2027.
• The Asia-Pacific Digital Diabetes Management Market size was estimated at USD 2,605.15 million in 2021 and expected to reach USD 3,123.61 million in 2022, at a CAGR 19.64% to reach USD 7,641.23 million by 2027.
• The Europe, Middle East & Africa Digital Diabetes Management Market size was estimated at USD 3,580.43 million in 2021 and expected to reach USD 4,243.40 million in 2022, at a CAGR 19.15% to reach USD 10,245.53 million by 2027.

Market Segmentation & Coverage:

The report on digital diabetes management identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. Our market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan.

This research report categorizes the digital diabetes management to forecast the revenues and analyze the trends in each of the following sub-markets:

Type:

• Handheld Devices
• Wearable Devices

Product:

• Apps
  • Digital Diabetes Management Apps
  • Weight & Diet Management Apps
• Devices
  • Continuous Glucose Monitoring (CGM) Systems
  • Smart Glucose Meters
  • Smart Insulin Pens
  • Smart Insulin Pumps/Closed-loop Pumps & Smart Insulin Patches

End-user:

• Hospitals & Specialty Diabetes Clinics
• Self/Home Healthcare

Region:

• Americas
  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
    • California
    • Florida
    • Illinois
    • New York
    • Ohio
    • Pennsylvania
    • Texas
• Asia-Pacific
  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
• Europe, Middle East & Africa
  • France
  • Germany
  • Italy
  • Netherlands
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • United Arab Emirates
  • United Kingdom

Company Usability Profiles:

• Abbott Laboratories
• Agamatrix, Inc.
• Ascensia Diabetes Care Holdings AG
• B. Braun Melsungen AG
• Becton, Dickinson and Company
• Care Innovations, LLC
• DarioHealth Corp.
• Dassault Systèmes SE
• decide Clinical Software GmbH
• Dexcom, Inc.
• F. Hoffmann-La Roche AG
• Glooko, Inc.
• GlucoMe
• Insulet Corporation
• LifeScan IP Holdings, LLC
• Medtronic PLC
• Orpyx Medical Technologies Inc.
• Sharecare, Inc.
• SocialDiabetes
• Spike Diabetes Assistant
• Tandem Diabetes Care, Inc.